According to IDEXX Laboratories's latest financial reports the company's current revenue (TTM) is $3.66 B. In 2022 the company made a revenue of $3.36 B an increase over the years 2021 revenue that were of $3.21 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $3.66 B | 8.72% |
2022 | $3.36 B | 4.73% |
2021 | $3.21 B | 18.79% |
2020 | $2.70 B | 12.45% |
2019 | $2.40 B | 8.75% |
2018 | $2.21 B | 12.4% |
2017 | $1.96 B | 10.91% |
2016 | $1.77 B | 10.83% |
2015 | $1.60 B | 7.81% |
2014 | $1.48 B | 7.9% |
2013 | $1.37 B | 6.47% |
2012 | $1.29 B | 6.13% |
2011 | $1.21 B | 10.45% |
2010 | $1.10 B | 6.96% |
2009 | $1.03 B | 0.74% |
2008 | $1.02 B | 11% |
2007 | $0.92 B | 24.82% |
2006 | $0.73 B | 15.83% |
2005 | $0.63 B | 16.19% |
2004 | $0.54 B | 15.38% |
2003 | $0.47 B | 15.34% |
2002 | $0.41 B | 6.89% |
2001 | $0.38 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Abbott Laboratories ABT | $40.10 B | 995.59% | ๐บ๐ธ USA |
Thermo Fisher Scientific TMO | $42.85 B | 1,070.65% | ๐บ๐ธ USA |
Henry Schein
HSIC | $12.33 B | 237.04% | ๐บ๐ธ USA |
Meridian Bioscience VIVO | $0.33 B | -90.90% | ๐บ๐ธ USA |
Neogen NEOG | $0.92 B | -74.62% | ๐บ๐ธ USA |
Heska Corporation
HSKA | $0.25 B | -93.04% | ๐บ๐ธ USA |
Petco WOOF | $6.15 B | 68.23% | ๐บ๐ธ USA |